Samsrita Labs Q2 FY27 Results: Net Loss of ₹0.3 Cr, Loss Narrows
Samsrita Labs Ltd reported a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Samsrita Labs Ltd reported a net loss of ₹0.3 Cr for Q2 FY27.
Samsrita Labs Limited intimated a board meeting on 11 November 2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026. Trading window remains closed until 48 hours after results.
Samsrita Labs held its first EGM for FY 2026-27 on October 26, 2026 by video conference. Members considered three material related-party resolutions, including a CCPS investment and an unsecured loan.
Samsrita Labs received ROC approval to alter its Memorandum of Association, enabling the company to provide veterinary care and wellness services for pet and companion animals.
Samsrita Labs Limited has issued a notice for an Extra-Ordinary General Meeting (EGM) to be held on October 26, 2026, to seek shareholder approval for related party transactions.
Samsrita Labs will invest up to ₹1 Crore in S Labs Hygiene Care via CCPS. It also approved a related-party sale transaction and a loan.